Leserbrief
Ethical considerations of unapproved injectable peptides marketed for skin anti-aging
Journal of the American Academy of Dermatology · 2026-08
DOI: 10.1016/j.jaad.2026.08.045 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the American Academy of Dermatology, 2026-08. Verfasst von Jenny Chung und 1 weiteren Autor:innen. Beteiligte Einrichtung: CUNY School of Medicine, New York, New York. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
antiagingdermatologydrug compoundingethicsinjectablepeptides
Autor:innen und Institutionen
- CUNY School of Medicine, New York, New York.
- Department of Dermatology, Weill Cornell Medicine, New York, New York. Electronic address: shl9032@med.cornell.edu.
Zitieren
APA
Chung, J., & Lipner, S. R. (2026). Ethical considerations of unapproved injectable peptides marketed for skin anti-aging. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.08.045
Vancouver
Chung J, Lipner SR. Ethical considerations of unapproved injectable peptides marketed for skin anti-aging. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.08.045
BibTeX
@article{Chung2026,
author = {Chung, Jenny and Lipner, Shari R},
title = {Ethical considerations of unapproved injectable peptides marketed for skin anti-aging},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2026.08.045}
}
EUVIMED